| [1] |
王莉霞. 糖尿病周围神经病变的发病机制概述[J]. 医药前沿, 2016, 6(24): 6-7.
|
| [2] |
Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy[J]. Diabetes, 2012, 28: 8-14.
|
| [3] |
Herrmann M, Sullivan DR, Veillard AS, et al. Serum 25-Hydroxyvitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes[J]. Diabetes Care, 2015, 38(3): 521-528.
|
| [4] |
Garcion E, Wionbarbot N, Monteromenei CN, et al. New clues about vitamin D functions in the nervous system[J]. Trends in Endocrinology and Metabolism, 2002, 13(3): 100-105.
|
| [5] |
Lv WS, Zhao WJ, Gong SL, et al. Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis[J]. Journal of Endocrinological Investigation, 2015, 38(5): 513-518.
|
| [6] |
Soderstrom LH, Johnson SP, Diaz VA, et al. Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES[J]. Diabetic Medicine, 2012, 29(1): 50-55.
|
| [7] |
Maser RE, Lenhard MJ, Pohlig RT. Vitamin D Insufficiency is Associated with Reduced Parasympathetic Nerve Fiber Function in Type 2 Diabetes[J]. Endocrine Practice, 2015, 21(2): 174-181.
|
| [8] |
Maestro B, Molero S, Bajo S, et al. Transcriptional activation of the human insulin receptor gene by 1, 25-dihydroxyvitamin D3[J]. Cell Biochemistry and Function, 2002, 20(3): 227-232.
|
| [9] |
Mirhosseini N, Vatanparast H, Mazidi M, et al. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis[J]. The Journal of Clinical Endocrinology & Metabolism, 2017, 102(9): 3097-3110.
|
| [10] |
Grammatiki M, Rapti E, Karras S, et al. Vitamin D and diabetes mellitus: Causal or casual association?[J]. Reviews in Endocrine and Metabolic Disorders, 2017, 18(2): 227-241.
|
| [11] |
Zeitz U, Weber K, Soegiarto DW, et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor[J]. The Faseb Journal, 2003, 17(3): 509-511.
|
| [12] |
Ojuka EO. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle[J]. Proceedings of the Nutrition Society, 2004, 63(2): 275-278.
|
| [13] |
Sooy K, Schermerhorn T, Noda M, et al. Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines[J]. Journal of Biological Chemistry, 1999, 274(48): 34343-34349.
|
| [14] |
Rabinovitch A, Suarez-Pinzon WL, Sooy K, et al. Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis[J]. Endocrinology, 2001, 142(8): 3649-3655.
|
| [15] |
Al-Khalidi B, Rotondi MA, Kimball SM, et al. Clinical utility of serum 25-hydroxyvitamin D in the diagnosis of insulin resistance and estimation of optimal 25-hydroxyvitamin D in U.S. adults[J]. Diabetes Research and Clinical Practice, 2017, 134(1): 80-90.
|
| [16] |
Jehle S, Lardi A, Felix B, et al. Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study[J]. Swiss Medical Weekly, 2014, 144: w13942.
|
| [17] |
Wimalawansa SJ. Associations of vitamin D with insulin resistance,obesity,type 2 diabetes,and metabolic syndrome[J]. Journal of Steroid Biochemistry and Molecular Biology, 2018, 175: 177-189.
|
| [18] |
Ahmadieh H, Azar ST, Lakkis N, et al. Hypovitaminosis D in Patients with Type 2 Diabetes Mellitus: A Relation to Disease Control and Complications[J]. Isrn Endocrinol, 2013, 2013: 1-7.
|
| [19] |
Lefebvre P, Chinetti G, Fruchart JC, et al. Sorting out the Roles of PPAR in Energy Metabolism and Vascular Homeostasis[J]. Journal of Clinical Investigation, 2006, 116(3): 571-580.
|
| [20] |
Rangwala SM, Lazar MA. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism[J]. Trends in Pharmacological Sciences, 2004, 25(6): 331-336.
|
| [21] |
Ning Conghua, Liu Lina, Lv Guodong, et al. Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats[J]. Lipids in Health and Disease, 2015, 14(1): 1-9.
|
| [22] |
Lee S, Lee DK, Choi E, et al. Identification of a functional vitamin D response element in the murine Insig-2 promoter and its potential role in the differentiation of 3T3-L1 preadipocytes[J]. Molecular Endocrinology, 2005, 19(2): 399-408.
|
| [23] |
Al-hazmi AS, Almehmadi MM, Albogami SM, et al. Vitamin D receptor gene polymorphisms as a risk factor for obesity in Saudi men[J]. Electronic Physician, 2017, 9(10): 5427-5433.
|
| [24] |
Lagunova Z, Porojnicu AC, Lindberg FA, et al. Vitamin D status in Norwegian children and adolescents with excess body weight[J]. Pediatric Diabetes, 2011, 12(2): 120-126.
|
| [25] |
Chung S, Ho C, Lam K, et al. Oxidative stress and diabetic complications[J]. Circulation Research, 2004, 107(9): 1058-1070.
|
| [26] |
Pantalone KM, Misrahebert AD, Hobbs TM, et al. Impact of Glycemic Control on the Diabetes Complications Severity Index Score and Development of Complications in People with Newly-diagnosed Type 2 Diabetes[J]. Journal of Diabetes, 2018, 10(3): 192-199.
|
| [27] |
Santos GC, Zeidler JD, Pérez-Valencia JA, et al. Metabolomic Analysis Reveals Vitamin D-induced Decrease in Polyol Pathway and Subtle Modulation of Glycolysis in HEK293T Cells[J]. Scientific Reports, 2017, 7(1): 9510-9523.
|
| [28] |
Chang JM, Kuo MC, Kuo HT, et al. 1-alpha, 25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells[J]. Journal of Laboratory and Clinical Medicine, 2004, 143(1): 14-22.
|
| [29] |
Garcion E, Sindji L, Leblondel G, et al. 1, 25-Dihydroxyvitamin D3 Regulates the Synthesis of-Glutamyl Transpeptidase and Glutathione Levels in Rat Primary Astrocytes[J]. Journal of Neurochemistry, 1999, 73(2): 859-866.
|
| [30] |
Anandabaskar N, Selvarajan S, Dkhar SA, et al. Effect of Vitamin D supplementation on vascular functions and oxidative stress in type 2 diabetic patients with Vitamin D deficiency[J]. Indian Journal of Endocrinology and Metabolism, 2017, 21(4): 555-563.
|
| [31] |
Cohen-Lahav M, Shany S, Tobvin D, et al. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels[J]. Nephrology Dialysis Transplantation, 2006, 21(4): 889-897.
|
| [32] |
Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance,obesity and diabetes[J]. Trends in Immunology, 2004, 25(1): 4-7.
|
| [33] |
Wolden-Kirk H, Overbergh L, Christesen HT, et al. Vitamin D and diabetes: its importance for beta cell and immune function[J]. Molecular and Cellular Endocrinology, 2011, 347(1): 106-120.
|
| [34] |
Christakos S, Dhawan P, Benn B, et al. Vitamin D: Molecular Mechanism of Action[J]. Annals of the New York Academy of Sciences, 2007, 1116(1): 340-348.
|
| [35] |
Borges AC, Feres T, Vianna LM, et al. Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol[J]. British Journal of Pharmacology, 1999, 127(3): 772-778.
|
| [36] |
Ginsberg HN. Insulin resistance and cardiovascular disease[J]. Journal of Clinical Investigation, 2000, 14(2): 453-458.
|
| [37] |
Deb DK, Chen Yunzi, Zhang Zhongyi, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-κB pathway[J]. American Journal of Physiology-Renal Physiology, 2009, 296(5): 1212-1218.
|
| [38] |
Suzuki T, Sekido H, Kato N, et al. Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway[J]. Journal of Neurochemistry, 2004, 91(6): 1430-1438.
|
| [39] |
Brewer LD, Thibault V, Chen KC, et al. Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons[J]. The Journal of Neuroscience, 2001, 21(1): 98-108.
|
| [40] |
Mascarenhas R, Mobarhan S. Hypovitaminosis D-induced Pain[J]. Nutrition Reviews, 2004, 62(9): 354-359.
|
| [41] |
Neveu I, Naveilhan P, Baudet C, et al. 1, 25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes[J]. Neuroreport, 1994, 6(1): 124-126.
|
| [42] |
Chabas JF, Stephan D, Marqueste T, et al. Cholecalciferol (Vitamin D3) Improves Myelination and Recovery after Nerve Injury[J]. PLoS One, 2013, 8(5): e65034.
|
| [43] |
Shehab D, Al-Jarallah K, Abdella N, et al. Prospective Evaluation of the Effect of Short-Term Oral Vitamin D Supplementation on Peripheral Neuropathy in Type 2 Diabetes Mellitus[J]. Medical Principles and Practice, 2015, 24(3): 250-256.
|
| [44] |
Premkumar LS, Pabbidi RM. Diabetic Peripheral Neuropathy: Role of Reactive Oxygen and Nitrogen Species[J]. Cell Biochemistry and Biophysics, 2013, 67(2): 373-383.
|
| [45] |
Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision[J]. European Journal of Neurology, 2010, 17(9): 1113-e88.
|
| [46] |
Calcutt N, Jolivalt C, Fernyhough P. Growth Factors as Therapeutics for Diabetic Neuropathy[J]. Current Drug Targets, 2008, 9(1): 47-59.
|